Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment (Q38402481)

2 September 2017

Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment (English)

1 reference

mild cognitive impairment

2 September 2017

1 reference

1 reference

based on heuristic

inferred from title

author

Alzheimer's Disease Neuroimaging Initiative

8

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

2 September 2017

Young Chul Youn

5

0 references

Jae-Sung Lim

object named as

Jae-Sung Lim

4

0 references

author name string

Byungseung Moon

1

1 reference

2 September 2017

Seongheon Kim

2

1 reference

2 September 2017

Young Ho Park

3

1 reference

2 September 2017

SangYun Kim

6

1 reference

2 September 2017

Jae-Won Jang

7

1 reference

2 September 2017

26 May 2017

1 reference

Journal of Alzheimer's Disease

2 September 2017

1 reference

2 September 2017

58

1 reference

2 September 2017

1255-1264

1 reference

2 September 2017

4

1 reference

Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression

2 September 2017

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Apathy is associated with increased amyloid burden in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

The rate of conversion of mild cognitive impairment to dementia: predictive role of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

A predictive depression pattern in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Progression from mild cognitive impairment to dementia: a 3-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Frontal Dysfunction Underlies Depression in Mild Cognitive Impairment: A FDG-PET Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Voxel-based morphometry–the methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Medial orbital frontal lesions in late-onset depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-170225

21 January 2018

Identifiers

DOI

10.3233/JAD-170225

1 reference

2 September 2017

1 reference